Product News and Recalls

Yaz/Beyaz Settlements: $220,000 average could cost Bayer

Bayer could end up paying billions of dollars settling lawsuits alleging that the German corporation’s Yasmin line of birth control pills caused blood clots.

In a settlement involving 500 lawsuits, news reports are claiming that the company is paying at least $110 million – amounting to about $220,000 a case.

In light of the fact that about 11,000 more lawsuits have been filed over injuries allegedly caused by the pills, the ...

continue reading...

Metal-on-metal hip implants recalled – New Zealand

An Australian newspaper reports that metal-on-metal hip implants are being recalled in New Zealand, following international reports that the devices have a high early failure rate.

According to “The Australian,” a some citizens are pursuing legal action against the device’s manufacturer, seeking compensation for pain, suffering and financial loss.

Similar legal actions are taking place in other countries against the manufacturers of metal-on-metal hip implants, including the United States.

The report says ...

continue reading...

Yaz Settlement News–Bayer settles 500 cases for $110 million

Bayer will pay at least $110 million, or an average of about $220,000 a case, to settle about 500 lawsuits over claims that its birth control pills caused blood clots, Bloomberg reports.

The lawsuits dealt with the company’s pills containing the compound drospirenone, which include Yasmin, Yaz, Ocella and Beyaz.

According to the Bloomberg report, the settlements came after a federal judge ...

continue reading...

Faulty hip joints were meant to be more durable

Ironically, a type of hip implant that’s prompted thousands of lawsuits was designed specifically to prevent the types of problems it’s allegedly causing on a wide scale, according to a report in “Arthritis Today.”The report mentions a study published in respected British medical journal “The Lancet,” which found that metal-on-metal artificial hip joints are far more likely to fail within five years than other available ...

continue reading...

Information about deep-vein thrombosis

Deep-vein thrombosis, or the formation of a blood clot in one of the body’s larger veins, affects an estimated 2 million Americans each year, according to the Coalition to Prevent Deep Vein Thrombosis.

The Coalition provides the following information about the condition:

• Deep-vein thrombosis most often occurs in the lower limbs, including the thigh or the calf.

• Only about half of the people with DVT experience symptoms. Sometimes DVT produces minimal or no symptoms.

• Symptoms of DVT may include pain, tenderness, ...

continue reading...

New J&J CEO involved in previous recall

A Newark Star-Ledger profile of Alex Gorsky, the new CEO of Johnson & Johnson, describes him as “the go-to man” during the company’s 1998 recall of Hismanal, an antihistamine that proved to have dangerous cardiovascular side effects.

Gorsky has succeeded previous chief executive officer William Weldon, who stepped down after a disastrous series of recalls. But the Star-Ledger mentions that some industry observers are questioning whether Gorsky played a part in marketing a hip implant that has generated thousands of lawsuits ...

continue reading...
Page 357 of 386 «...330340350355356357358359...»